NICTA has spun out Saluda Medical, a company with technology for pain relief via spinal cord stimulation.
A cross-disciplinary team including researchers from NICTA, the University of Melbourne, and the Epworth and Royal Melbourne hospitals will look for a way to use genetic information to determine whether prostate cancer sufferers have the aggressive form of the disease.
Hi Con, thank you! Tom made it easy, he knows his stuff. Looking forward to the event!
Good work shining a spotlight on this Sam. You appear to be the only one paying any attention to it[…]
Alex, really good interview navigating the breadth of our current Covid norm and the scope of Zebra's technology path in[…]
Fletcher is continuing to reinforce his reputation of being an irrelevant twit who should be prosecuted for thieving oxygen.
i'm sure the merger may be ok... but you still have the lack of 5G issue.